Medication info

Winnerphery Injection

Prescription medicationSolutionInjection
Ingredient · strength
Glucose Monohydrate›143gL-Isoleucine›6gL-Leucine›7.3gL-Methionine›4gL-Phenylalanine›5.6gL-Threonine›4.2gL-Tryptophan›1.8gL-Valine›5.8gL-Arginine›11.5gL-Histidine›4.8gL-Alanine›20.7gGlycine›10.3gL-Proline›6.8gL-Serine›5gL-Tyrosine›0.4gL-Lysine Hydrochloride›7.25gCalcium Chloride Hydrate›0.74gMagnesium Sulfate Heptahydrate›2.47gZinc Sulfate Heptahydrate›0.023gPotassium Chloride›4.48gSodium Glycerophosphate Pentahydrate›5.92gSodium Acetate Hydrate›5.62gRefined Soyabean Oil›60gTriglycerides Medium-Chain›50gPurified Olive Oil›50gPurified Fish Oil (High Dose Omega-3 Fatty Acids)›40g
Manufacturer / importer
JW Life Science Co., Ltd.
Appearance
This product consists of an inner and outer packaging divided into three compartments, with an oxygen absorber pouch in between. Each compartment contains a glucose solution, amino acids, and electrolyte solution, and
Packaging
217 mL (Solution A 118 mL, Solution B 68 mL, Solution C 31 mL) / bag, 241 mL (Solution A 131 mL, Solution B 76 mL, Solution C 34 mL) / bag, 362 mL (Solution A 197 mL, Solution B 114 mL, Solution C 51 mL) / bag, 502 mL (Solution A 273 mL, Solution B 158 mL, Solution C 71 mL) / bag, 654 mL (Solution A 356 mL, Solution B 206 mL, Solution C 92 mL) / bag, 1085 mL (
Approval status
Active

MFDS item code 201309523 · Approved 2013.09.30 · Insurance code 678900991,678900992,678900993,678900995,

Summary

Main use
Correction of deficiencies in nutrition (amino acids, calories, fatty acids, etc.), fluids, and electrolytes
Who receives it
Adults · Children
Adult administration
The dose and infusion rate are determined according to the patient's ability to clear fat, metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9g/kg as amino acids) - Patients experiencing moderate to high metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or pronounced anabolic states), the nitrogen requirement may be higher. Dose A daily dose of 20-40 mL/kg of this drug corresponds to 0.10-0.20 g/kg of nitrogen (0.6-1.3 g/kg of amino acids) and total calories of 14-28kcal/kg (12-24 kcal/kg non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to glucose 0.21g/kg per hour, amino acids 0.09g/kg per hour, and fat 0.08g/kg per hour). The recommended infusion period is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides 0.20g/kg of nitrogen (amino acids 1.3g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total calories of 28 kcal/kg (equivalent to 24 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a peripheral or central vein.
Child administration
Use in children is not recommended.

Ingredients

Manufacturer
JW Life Science Co., Ltd.

Efficacy & effects

Correction of deficiencies in nutrition (amino acids, calories, fatty acids, etc.), fluids, and electrolytes

View approved original text

This medication provides essential hydration, electrolytes, amino acids, calories, essential fatty acids, and omega-3 fatty acids to patients who are unable to obtain adequate nutrition orally or via the gastrointestinal tract. It helps patients to receive sufficient nutrition, which plays a crucial role in improving their nutritional status and facilitating recovery. Therefore, it is used safely and effectively for patients requiring intravenous nutrient supply.

How it is given

Adult administration

The dose and infusion rate are determined according to the patient's ability to clear fat, metabolize nitrogen and glucose, and nutritional requirements; the dose and bag size are determined according to the patient's condition and body weight. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. - Patients with normal nutritional status or mild metabolic stress: 0.10-0.15 g/kg/day as nitrogen (0.6-0.9g/kg as amino acids) - Patients experiencing moderate to high metabolic stress, regardless of nutritional status: 0.15-0.25 g/kg/day as nitrogen (0.9-1.6 g/kg as amino acids) In very special cases (e.g., burns or pronounced anabolic states), the nitrogen requirement may be higher. Dose A daily dose of 20-40 mL/kg of this drug corresponds to 0.10-0.20 g/kg of nitrogen (0.6-1.3 g/kg of amino acids) and total calories of 14-28kcal/kg (12-24 kcal/kg non-protein calories). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to glucose 0.21g/kg per hour, amino acids 0.09g/kg per hour, and fat 0.08g/kg per hour). The recommended infusion period is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides 0.20g/kg of nitrogen (amino acids 1.3g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total calories of 28 kcal/kg (equivalent to 24 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a peripheral or central vein.

Child administration

Use in children is not recommended.

Precautions

This medication must be used strictly according to a physician's instructions, and if allergic reactions such as fever, chills, rashes, or breathing difficulties occur, administration should be immediately discontinued. When used in conjunction with calcium-containing preparations intravenously, ceftriaxone can precipitate calcium, so the same infusion device should not be used simultaneously. Caution is needed in administering this medication to premature or low-birth-weight infants as levels of free fatty acids in plasma can increase. Patients with allergies to fish, eggs, soybeans, peanuts, or those with severe hyperlipidemia, liver dysfunction, or bleeding disorders should not use this medication. Patients with renal failure, diabetes, liver dysfunction, or issues with lipid metabolism should use it with caution. During administration, blood triglyceride levels should be periodically checked to prevent the occurrence of fat overload syndrome. Excessive administration of amino acids or glucose can cause side effects such as nausea, vomiting, and hyperglycemia, so recommended doses and rates should be adhered to. This product contains soybean oil, fish oil, and egg yolk phospholipids, which may cause allergic reactions, though infrequently, so patients with a history of allergies should be cautious. The safety for pregnant or breastfeeding women has not been established; it should only be used if the therapeutic benefit outweighs the risk. Before and after administration, blood tests and monitoring of electrolytes and fluid status should be carefully observed, and strict aseptic technique should be implemented to prevent infection. In case of excessive dosing, the infusion rate should be slowed or stopped, and if necessary, appropriate emergency measures such as insulin administration or dialysis should be taken. This medication should be stored at a temperature between 1°C and 25°C to avoid exposure to air and humidity.

Side effects

  • Dizziness
  • headache
  • abdominal discomfort
  • indigestion
  • bloody stools
  • nausea
  • increased serum amylase
  • facial flushing
  • thrombophlebitis
  • back pain
Show 14 more
  • flank pain
  • fever
  • surgical site pain
  • sweating
  • pruritus
  • hyperlipidemia
  • emesis
  • vomiting
  • tremors
  • sweating
  • rise in body temperature
  • hyperglycemia
  • allergic reactions
  • increased C-reactive protein (CRP)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and humidity from entering, ideally at room temperature between 1°C and 25°C. Proper storage will maintain the efficacy of the medication and prevent degradation.

Appearance and packaging

Appearance

This product consists of an inner and outer packaging divided into three compartments, with an oxygen absorber pouch in between. Each compartment contains a glucose solution, amino acids, and electrolyte solution, and

Package unit

217 mL (Solution A 118 mL, Solution B 68 mL, Solution C 31 mL) / bag, 241 mL (Solution A 131 mL, Solution B 76 mL, Solution C 34 mL) / bag, 362 mL (Solution A 197 mL, Solution B 114 mL, Solution C 51 mL) / bag, 502 mL (Solution A 273 mL, Solution B 158 mL, Solution C 71 mL) / bag, 654 mL (Solution A 356 mL, Solution B 206 mL, Solution C 92 mL) / bag, 1085 mL (

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.